A detailed history of Cic Wealth, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cic Wealth, LLC holds 9,681 shares of GILD stock, worth $873,129. This represents 0.21% of its overall portfolio holdings.

Number of Shares
9,681
Previous 9,667 0.14%
Holding current value
$873,129
Previous $663 Million 22.37%
% of portfolio
0.21%
Previous 0.18%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$66.59 - $83.99 $932 - $1,175
14 Added 0.14%
9,681 $812 Million
Q2 2024

Jul 12, 2024

SELL
$63.15 - $72.88 $118,216 - $136,431
-1,872 Reduced 16.22%
9,667 $663 Million
Q1 2024

Apr 15, 2024

BUY
$71.58 - $87.29 $172,579 - $210,456
2,411 Added 26.41%
11,539 $845 Million
Q4 2023

Jan 11, 2024

BUY
$73.27 - $83.09 $668,808 - $758,445
9,128 New
9,128 $739 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Cic Wealth, LLC Portfolio

Follow Cic Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cic Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cic Wealth, LLC with notifications on news.